4.5 Article

Extracellular Vesicles in Type 1 Diabetes: A Versatile Tool

期刊

BIOENGINEERING-BASEL
卷 9, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/bioengineering9030105

关键词

-

资金

  1. Karen Toffler Charitable Trust as part of the Toffler Scholar Program [F09048]

向作者/读者索取更多资源

Type 1 diabetes is a chronic autoimmune disease that affects a large number of people, and extracellular vesicles (EVs) have the potential to be used as biomarkers for diagnosis and treatment. EVs contain diverse active components and can be transported to specific cells/tissues through the blood system.
Type 1 diabetes is a chronic autoimmune disease affecting nearly 35 million people. This disease develops as T-cells continually attack the beta-cells of the islets of Langerhans in the pancreas, which leads to beta-cell death, and steadily decreasing secretion of insulin. Lowered levels of insulin minimize the uptake of glucose into cells, thus putting the body in a hyperglycemic state. Despite significant progress in the understanding of the pathophysiology of this disease, there is a need for novel developments in the diagnostics and management of type 1 diabetes. Extracellular vesicles (EVs) are lipid-bound nanoparticles that contain diverse content from their cell of origin and can be used as a biomarker for both the onset of diabetes and transplantation rejection. Furthermore, vesicles can be loaded with therapeutic cargo and delivered in conjunction with a transplant to increase cell survival and long-term outcomes. Crucially, several studies have linked EVs and their cargos to the progression of type 1 diabetes. As a result, gaining a better understanding of EVs would help researchers better comprehend the utility of EVs in regulating and understanding type 1 diabetes. EVs are a composition of biologically active components such as nucleic acids, proteins, metabolites, and lipids that can be transported to particular cells/tissues through the blood system. Through their varied content, EVs can serve as a flexible aid in the diagnosis and management of type 1 diabetes. In this review, we provide an overview of existing knowledge about EVs. We also cover the role of EVs in the pathogenesis, detection, and treatment of type 1 diabetes and the function of EVs in pancreas and islet beta-cell transplantation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据